Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Prima BioMed Ltd (IMMP) had Normalized Income after Taxes of $-53.82M for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
$16.40M |
|
$-53.82M |
|
-- |
|
$16.40M |
|
$68.95M |
|
$-52.55M |
|
$-1.28M |
|
$-53.82M |
|
$-53.82M |
|
$-53.82M |
|
$-53.82M |
|
$-53.82M |
|
|
Normalized Income after Taxes |
$-53.82M |
$-52.55M |
|
$-50.87M |
|
147.16M |
|
147.16M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$54.72M |
|
$0.08M |
|
$1.79M |
|
$56.51M |
|
$9.61M |
|
-- |
|
$5.14M |
|
$14.75M |
|
$41.76M |
|
$40.75M |
|
$41.76M |
|
147.37M |
|
| Cash Flow Statement Financials | |
$-37.64M |
|
$38.32M |
|
$-0.15M |
|
$45.75M |
|
$43.21M |
|
$-2.54M |
|
$1.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|